论文部分内容阅读
目前，正在研究开发的新的抗结核药有下列几种类型：利福平类药物 （１）ＫＲＭ－１６４８（ｂｅｎｚｏｘ－ａｚｉｎｏｒｉｆａｍｙｃｉｎ）：它是新合成的利福平衍生物。动物实验证明，该药对结核菌有抗菌活性；在巨噬细胞内对结核菌有杀菌作用。它在血清内的浓度比利福平稍
Currently, there are the following new types of anti-TB drugs under research and development: Rifampicin (1) Benzoxazinifamycin (KRM-1648): It is a newly synthesized rifampicin derivative. Animal experiments show that the drug has antibacterial activity against Mycobacterium tuberculosis; bactericidal effect on TB in macrophages. Its concentration in serum is slightly less than rifampicin